Abstract
Neurofibromatosis 1 (NF1) is caused by mutations in the NF1 gene, which encodes the protein, neurofibromin, an inhibitor of Ras activity. Cortical GABAergic interneurons (CINs) are implicated in NF1 pathology, but the cellular and molecular changes to CINs are unknown. We deleted mouse Nf1 from the medial ganglionic eminence, which gives rise to both oligodendrocytes and CINs that express somatostatin and parvalbumin. Nf1 loss led to a persistence of immature oligodendrocytes that prevented later-generated oligodendrocytes from occupying the cortex. Moreover, molecular and cellular properties of parvalbumin (PV)-positive CINs were altered by the loss of Nf1, without changes in somatostatin (SST)-positive CINs. We discovered that loss of Nf1 results in a dose-dependent decrease in Lhx6 expression, the transcription factor necessary to establish SST+ and PV+ CINs, which was rescued by the MEK inhibitor SL327, revealing a mechanism whereby a neurofibromin/Ras/MEK pathway regulates a critical CIN developmental milestone.
Keywords
MGE
cortical interneuron
oligodendrocyte
MeSH 主题词
Aminoacetonitrile/administration & dosage,analogs & derivatives
Animals
Cells, Cultured
Cerebral Cortex/cytology,pathology
Disease Models, Animal
Embryo, Mammalian
Female
GABAergic Neurons/metabolism,pathology
Humans
Interneurons/metabolism,pathology
LIM-Homeodomain Proteins/metabolism
MAP Kinase Signaling System/drug effects
Median Eminence/cytology
Mice
Mice, Knockout
Nerve Tissue Proteins/metabolism
Neurofibromatosis 1/genetics,pathology
Neurofibromin 1/genetics,metabolism
Neuroglia/cytology
Parvalbumins/metabolism
Primary Cell Culture
Somatostatin/metabolism
Transcription Factors/metabolism
ras GTPase-Activating Proteins/metabolism
化学物质
LHX6 protein, mouse
LIM-Homeodomain Proteins
Nerve Tissue Proteins
Neurofibromin 1
Parvalbumins
SL 327
Transcription Factors
ras GTPase-Activating Proteins
Aminoacetonitrile
Somatostatin
作者与单位
共 9 位作者,点击展开单位 / ORCID
Angara Kartik
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503.
Pai Emily Ling-Lin
Department of Psychiatry, University of California, San Francisco, CA 94158. | Neuroscience Program, University of California, San Francisco, CA 94158. | Nina Ireland Laboratory of Developmental Neurobiology, University of California, San Francisco, CA 94158.
Bilinovich Stephanie M
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503.
Stafford April M
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503.
Nguyen Julie T
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503.
Li Katie X
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503.
Paul Anirban
Department of Neural and Behavioral Sciences, PennState University, Hershey, PA 17033.
Rubenstein John L
Department of Psychiatry, University of California, San Francisco, CA 94158. | Neuroscience Program, University of California, San Francisco, CA 94158. | Nina Ireland Laboratory of Developmental Neurobiology, University of California, San Francisco, CA 94158.
Vogt Daniel
ORCID
Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503; vogtdan2@msu.edu. | Neuroscience Program, Michigan State University, Grand Rapids, MI 49503.